TFS Partners With OmniComm to Use TrialMaster® EDC
TFS International has signed a new three-year partnership agreement with OmniComm Systems, Inc. in which TFS will use OmniComm’s TrialMaster EDC technology to develop clinical studies in multiple TFS research sites around the world. Clinical trial managment along with new medicines being brought to the market are a few of the benefits to this collaboration.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
